TrianglePUBLICATIONS · 21514146
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Eur J Cancer
- Publication date
- 2011 Jun
- First author
- Vrooman LM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Vrooman LM
- type
- Author
- name
- Neuberg DS
- type
- Author
- name
- Stevenson KE
- type
- Author
- name
- Asselin BL
- type
- Author
- name
- Athale UH
- type
- Author
- name
- Clavell L
- type
- Author
- name
- Cole PD
- type
- Author
- name
- Kelly KM
- type
- Author
- name
- Larsen EC
- type
- Author
- name
- Laverdière C
- type
- Author
- name
- Michon B
- type
- Author
- name
- Schorin M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Vrooman LM
- type
- Author
- name
- Neuberg DS
- type
- Author
- name
- Stevenson KE
- type
- Author
- name
- Asselin BL
- type
- Author
- name
- Athale UH
- type
- Author
- name
- Clavell L
- type
- Author
- name
- Cole PD
- type
- Author
- name
- Kelly KM
- type
- Author
- name
- Larsen EC
- type
- Author
- name
- Laverdière C
- type
- Author
- name
- Michon B
- type
- Author
- name
- Schorin M
- type
- Author
- bibliography ids
- nci-bib-f8a6875548c8cfdb6283dcfe
- book metadata
- content sha256
- 735691e790ff347366f91207ee76bce2984ac0cb1b03c5581cdc52684155f73a
- document type
- citation
- dois
- 10.1016/j.ejca.2011.03.022
- electronic publication date
- display
- 2011 Apr 20
- precision
- day
- year
- 2011
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:21514146
- immutable id
- pubmed:21514146@735691e790ff347366f91207ee76bce2984ac0cb1b03c5581cdc52684155f73a
- journal
- abbreviation
- Eur J Cancer
- issn electronic
- 1879-0852
- issn print
- 0959-8049
- issue
- 9
- name
- European journal of cancer (Oxford, England : 1990)
- nlm unique id
- 9005373
- pages
- 1373-9
- volume
- 47
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 21514146
- provenance
- batch id
- a366a1bc8ed89d8d7ca5
- provider
- NCBI PubMed ESummary
- record sha256
- 0447942b95b039659b573416f39f8045a70c3c730034fedc555c2443a61a4ae3
- response sha256
- c4fde29a469958f2f95ac1ef059ab1994169370e37d8293c0823efce81dabbb8
- retrieved at
- 2026-09-09T23:46:40.540025+00:00
- publication date
- display
- 2011 Jun
- precision
- month
- year
- 2011
- publication types
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.
Preserved source evidence · Not medical advice